Simplify Medical received its 60th U.S. patent, addressing assembly of its cervical disc replacement with mobile core retention technology.
The patent, No. 10,219,911, is titled Prosthetic Disc for Intervertebral Insertion and relates to a method for assembling a cervical disc replacement in which a mobile core is retained. Other recent patents include U.S. Patent No. 10,206,785, covering proprietary methods to enhance radiographic imaging of radiolucent implants, and U.S. Patent No. 10,166,113, relating to intervertebral discs with a movable core and additional core retention technology claims.
Simplify is a PEEK-on-ceramic motion-preserving artificial disc that is is designed to be clearly viewed on MRI with minimal artifact, potentially protecting patients from radiation associated with CT scans. In 4Q18, the company completed enrollment and treatment of all patients in its U.S. Investigational Device Exemption pivotal trial of the device in two contiguous levels from C3 to C7, compared with two-level anterior cervical discectomy and fusion.
Simplify Medical received its 60th U.S. patent, addressing assembly of its cervical disc replacement with mobile core retention technology.
The patent, No. 10,219,911, is titled Prosthetic Disc for Intervertebral Insertion and relates to a method for assembling a cervical disc replacement in which a mobile core is retained. Other recent...
Simplify Medical received its 60th U.S. patent, addressing assembly of its cervical disc replacement with mobile core retention technology.
The patent, No. 10,219,911, is titled Prosthetic Disc for Intervertebral Insertion and relates to a method for assembling a cervical disc replacement in which a mobile core is retained. Other recent patents include U.S. Patent No. 10,206,785, covering proprietary methods to enhance radiographic imaging of radiolucent implants, and U.S. Patent No. 10,166,113, relating to intervertebral discs with a movable core and additional core retention technology claims.
Simplify is a PEEK-on-ceramic motion-preserving artificial disc that is is designed to be clearly viewed on MRI with minimal artifact, potentially protecting patients from radiation associated with CT scans. In 4Q18, the company completed enrollment and treatment of all patients in its U.S. Investigational Device Exemption pivotal trial of the device in two contiguous levels from C3 to C7, compared with two-level anterior cervical discectomy and fusion.
Copy to clipboard 
